GSK Investigational Site

Pasadena, Texas 77505

1 studies enrolling now · 4 studies all time

What they study most

Crohn's Disease, Diabetes Mellitus, Type 2, Irritable Bowel Syndrome (IBS), Irritable Colon, Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease

Studies at this site

• A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH — Recruiting now
• A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease — Completed
• Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only — Completed
• Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy — Completed